Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantation.
Details
Serval ID
serval:BIB_53C7CE1D6B7C
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantation.
Journal
EuroIntervention
ISSN
1969-6213 (Electronic)
ISSN-L
1774-024X
Publication state
Published
Issued date
07/10/2024
Peer-reviewed
Oui
Volume
20
Number
19
Pages
e1248-e1528
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Abstract
Severe aortic stenosis (AS) is associated with left ventricular (LV) remodelling, likely causing alterations in coronary blood flow and microvascular resistance.
We aimed to evaluate changes in absolute coronary flow and microvascular resistance in patients with AS undergoing transcatheter aortic valve implantation (TAVI).
Consecutive patients with AS undergoing TAVI with non-obstructive coronary artery disease in the left anterior descending artery (LAD) were included. Absolute coronary flow (Q) and microvascular resistance (R <sub>μ</sub> ) were measured in the LAD using continuous intracoronary thermodilution at rest and during hyperaemia before and after TAVI, and at 6-month follow-up. Total myocardial mass and LAD-specific mass were quantified by echocardiography and cardiac computed tomography. Regional myocardial perfusion (Q <sub>N</sub> ) was calculated by dividing absolute flow by the subtended myocardial mass.
In 51 patients, Q and R were measured at rest and during hyperaemia before and after TAVI; in 20 (39%) patients, measurements were also obtained 6 months after TAVI. No changes occurred in resting and hyperaemic flow and resistance before and after TAVI nor after 6 months. However, at 6-month follow-up, a notable reverse LV remodelling resulted in a significant increase in hyperaemic perfusion (Q <sub>N,hyper</sub> : 0.86 [interquartile range {IQR} 0.691.06] vs 1.20 [IQR 0.99-1.32] mL/min/g; p=0.008; pre-TAVI and follow-up, respectively) but not in resting perfusion (Q <sub>N,rest</sub> : 0.34 [IQR 0.30-0.48] vs 0.47 [IQR 0.36-0.67] mL/min/g; p=0.06).
Immediately after TAVI, no changes occurred in absolute coronary flow or coronary flow reserve. Over time, the remodelling of the left ventricle is associated with increased hyperaemic perfusion.
We aimed to evaluate changes in absolute coronary flow and microvascular resistance in patients with AS undergoing transcatheter aortic valve implantation (TAVI).
Consecutive patients with AS undergoing TAVI with non-obstructive coronary artery disease in the left anterior descending artery (LAD) were included. Absolute coronary flow (Q) and microvascular resistance (R <sub>μ</sub> ) were measured in the LAD using continuous intracoronary thermodilution at rest and during hyperaemia before and after TAVI, and at 6-month follow-up. Total myocardial mass and LAD-specific mass were quantified by echocardiography and cardiac computed tomography. Regional myocardial perfusion (Q <sub>N</sub> ) was calculated by dividing absolute flow by the subtended myocardial mass.
In 51 patients, Q and R were measured at rest and during hyperaemia before and after TAVI; in 20 (39%) patients, measurements were also obtained 6 months after TAVI. No changes occurred in resting and hyperaemic flow and resistance before and after TAVI nor after 6 months. However, at 6-month follow-up, a notable reverse LV remodelling resulted in a significant increase in hyperaemic perfusion (Q <sub>N,hyper</sub> : 0.86 [interquartile range {IQR} 0.691.06] vs 1.20 [IQR 0.99-1.32] mL/min/g; p=0.008; pre-TAVI and follow-up, respectively) but not in resting perfusion (Q <sub>N,rest</sub> : 0.34 [IQR 0.30-0.48] vs 0.47 [IQR 0.36-0.67] mL/min/g; p=0.06).
Immediately after TAVI, no changes occurred in absolute coronary flow or coronary flow reserve. Over time, the remodelling of the left ventricle is associated with increased hyperaemic perfusion.
Keywords
Humans, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Female, Male, Aged, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/physiopathology, Aged, 80 and over, Coronary Circulation/physiology, Vascular Resistance, Coronary Artery Disease/physiopathology, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Ventricular Remodeling, Treatment Outcome, Echocardiography/methods, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Coronary Vessels/physiopathology, Coronary Vessels/diagnostic imaging
Pubmed
Create date
11/10/2024 13:13
Last modification date
11/10/2024 19:15